Effects of Remote-based Resistance Training on Cardiometabolic Risk Factors, Cognitive Function, and Quality of Life in Adults Living With Alzheimer's Disease and/or Related Dementias
Primary Purpose
Dementia, Alzheimer Disease, Dementia, Vascular
Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Remote-based Resistance Exercise Training
Sponsored by
About this trial
This is an interventional treatment trial for Dementia
Eligibility Criteria
Inclusion Criteria:
- 55 years of age or older
- Sedentary or not meeting the current physical activity guidelines of at least 150 minutes of moderate-to-vigorous physical activity per week
- Live with or have a primary in-home caregiver or legal representative who can be physically present during the remote-based exercise sessions
- Have access to a computer, tablet, or smartphone with internet and webcam access for the HIPAA compliant virtual Zoom meetings.
Exclusion Criteria:
- Younger than 55 years of age
- Accustomed to resistance exercise training during the previous year
- Live with known or suggestive uncontrolled cardiovascular, metabolic, and/or renal disease
- Live with musculoskeletal injury that precludes their ability to perform remote-based, resistance exercise training
Sites / Locations
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Remote-based Resistance Exercise Training
Arm Description
All participants enrolled in the trial will receive supervised remote-based resistance exercise training. The exercises will be performed with the use of Therabands and will include 8-10 exercises performed for 1 set of 15 repetitions, performed 3 days per week for 24 weeks.
Outcomes
Primary Outcome Measures
Resting systolic blood pressure, measured in mmHg from 0 and above with higher numbers indicating higher blood pressure
Resting systolic blood pressure will be measured with an automated blood pressure device, measured in mmHg from 0 and above with higher numbers indicating higher blood pressure
Resting systolic blood pressure, measured in mmHg from 0 and above with higher numbers indicating higher blood pressure
Resting systolic blood pressure will be measured with an automated blood pressure device, measured in mmHg from 0 and above with higher numbers indicating higher blood pressure
Resting systolic blood pressure, measured in mmHg from 0 and above with higher numbers indicating higher blood pressure
Resting systolic blood pressure will be measured with an automated blood pressure device, measured in mmHg from 0 and above with higher numbers indicating higher blood pressure
Resting diastolic blood pressure, measured in mmHg from 0 and above with higher numbers indicating higher blood pressure
Resting diastolic blood pressure will be measured with an automated blood pressure device, measured in mmHg from 0 and above with higher numbers indicating higher blood pressure
Resting diastolic blood pressure, measured in mmHg from 0 and above with higher numbers indicating higher blood pressure
Resting diastolic blood pressure will be measured with an automated blood pressure device, measured in mmHg from 0 and above with higher numbers indicating higher blood pressure
Resting diastolic blood pressure, measured in mmHg from 0 and above with higher numbers indicating higher blood pressure
Resting diastolic blood pressure will be measured with an automated blood pressure device, measured in mmHg from 0 and above with higher numbers indicating higher blood pressure
Height, red with a stadiometer in inches from 0 and above with higher numbers indicating taller height
Height will be measured with a stadiometer in inches from 0 and above with higher numbers indicating taller height
Height, red with a stadiometer in inches from 0 and above with higher numbers indicating taller height
Height will be measured with a stadiometer in inches from 0 and above with higher numbers indicating taller height
Height, red with a stadiometer in inches from 0 and above with higher numbers indicating taller height
Height will be measured with a stadiometer in inches from 0 and above with higher numbers indicating taller height
Weight, ured with a physican scale in pounds from 0 and above with higher numbers indicating heavier weight
Weight will be measured with a physican scale in pounds from 0 and above with higher numbers indicating heavier weight
Weight, ured with a physican scale in pounds from 0 and above with higher numbers indicating heavier weight
Weight will be measured with a physican scale in pounds from 0 and above with higher numbers indicating heavier weight
Weight, ured with a physican scale in pounds from 0 and above with higher numbers indicating heavier weight
Weight will be measured with a physican scale in pounds from 0 and above with higher numbers indicating heavier weight
Body mass index, measured in meters squared, from 0 and above wiith larger values indicating a higher body mass index
Body mass index will be measured as the weight measured in kilograms divided by the height measured in meters squared, from 0 and above wiith larger values indicating a higher body mass index
Body mass index, measured in meters squared, from 0 and above wiith larger values indicating a higher body mass index
Body mass index will be measured as the weight measured in kilograms divided by the height measured in meters squared, from 0 and above wiith larger values indicating a higher body mass index
Body mass index, measured in meters squared, from 0 and above wiith larger values indicating a higher body mass index
Body mass index will be measured as the weight measured in kilograms divided by the height measured in meters squared, from 0 and above wiith larger values indicating a higher body mass index
Waist circumference, red in inches with a Gulick tape measure from 0 and above with higher numbers indicating a larger waist circumference
Waist circumference will be measured in inches with a Gulick tape measure from 0 and above with higher numbers indicating a larger waist circumference
Waist circumference, red in inches with a Gulick tape measure from 0 and above with higher numbers indicating a larger waist circumference
Waist circumference will be measured in inches with a Gulick tape measure from 0 and above with higher numbers indicating a larger waist circumference
Waist circumference, red in inches with a Gulick tape measure from 0 and above with higher numbers indicating a larger waist circumference
Waist circumference will be measured in inches with a Gulick tape measure from 0 and above with higher numbers indicating a larger waist circumference
Hip circumference, sured in inches with a Gulick tape measure from 0 and above with higher numbers indicating a larger waist circumference
Hip circumference will be measured in inches with a Gulick tape measure from 0 and above with higher numbers indicating a larger waist circumference
Hip circumference, sured in inches with a Gulick tape measure from 0 and above with higher numbers indicating a larger waist circumference
Hip circumference will be measured in inches with a Gulick tape measure from 0 and above with higher numbers indicating a larger waist circumference
Hip circumference, sured in inches with a Gulick tape measure from 0 and above with higher numbers indicating a larger waist circumference
Hip circumference will be measured in inches with a Gulick tape measure from 0 and above with higher numbers indicating a larger waist circumference
Blood glucose, measured in mg/dL from 0 and above with larger values indicating a higher blood glucose concentration
Blood glucose will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher blood glucose concentration
Blood glucose, measured in mg/dL from 0 and above with larger values indicating a higher blood glucose concentration
Blood glucose will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher blood glucose concentration
Blood glucose, measured in mg/dL from 0 and above with larger values indicating a higher blood glucose concentration
Blood glucose will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher blood glucose concentration
High density lipoprotein cholesterol, ed in mg/dL from 0 and above with larger values indicating a higher high density lipoprotein concentrations, a desirable finding
High density lipoprotein cholesterol will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher high density lipoprotein concentrations, a desirable finding
High density lipoprotein cholesterol, ed in mg/dL from 0 and above with larger values indicating a higher high density lipoprotein concentrations, a desirable finding
High density lipoprotein cholesterol will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher high density lipoprotein concentrations, a desirable finding
High density lipoprotein cholesterol, ed in mg/dL from 0 and above with larger values indicating a higher high density lipoprotein concentrations, a desirable finding
High density lipoprotein cholesterol will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher high density lipoprotein concentrations, a desirable finding
Low density lipoprotein cholesterol, measured in mg/dL from 0 and above with larger values indicating a higher low density lipoprotein concentrations, an undesirable finding
Low density lipoprotein cholesterol will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher low density lipoprotein concentrations, an undesirable finding
Low density lipoprotein cholesterol, measured in mg/dL from 0 and above with larger values indicating a higher low density lipoprotein concentrations, an undesirable finding
Low density lipoprotein cholesterol will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher low density lipoprotein concentrations, an undesirable finding
Low density lipoprotein cholesterol, measured in mg/dL from 0 and above with larger values indicating a higher low density lipoprotein concentrations, an undesirable finding
Low density lipoprotein cholesterol will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher low density lipoprotein concentrations, an undesirable finding
Triglycerides, measured in mg/dL from 0 and above with larger values indicating a higher triglyceride concentrations, an undesirable finding
Triglycerides will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher triglyceride concentrations, an undesirable finding
Triglycerides, measured in mg/dL from 0 and above with larger values indicating a higher triglyceride concentrations, an undesirable finding
Triglycerides will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher triglyceride concentrations, an undesirable finding
Triglycerides, measured in mg/dL from 0 and above with larger values indicating a higher triglyceride concentrations, an undesirable finding
Triglycerides will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher triglyceride concentrations, an undesirable finding
Total cholesterol, measured in mg/dL from 0 and above with larger values indicating a higher total cholesterol concentrations, an undesirable finding
Total cholesterol will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher total cholesterol concentrations, an undesirable finding
Total cholesterol, measured in mg/dL from 0 and above with larger values indicating a higher total cholesterol concentrations, an undesirable finding
Total cholesterol will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher total cholesterol concentrations, an undesirable finding
Total cholesterol, measured in mg/dL from 0 and above with larger values indicating a higher total cholesterol concentrations, an undesirable finding
Total cholesterol will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher total cholesterol concentrations, an undesirable finding
Secondary Outcome Measures
Cognitive Function as Measured by the Montreal Cognitive Assessment
Cognitive function will be assessed with the Montreal Cognitive Assessment Screen, measured from 0 to 30 with higher scores indicating better cognitive function
Cognitive Function as Measured by the Montreal Cognitive Assessment
Cognitive function will be assessed with the Montreal Cognitive Assessment Screen, measured from 0 to 30 with higher scores indicating better cognitive function
Cognitive Function as Measured by the Montreal Cognitive Assessment
Cognitive function will be assessed with the Montreal Cognitive Assessment Screen, measured from 0 to 30 with higher scores indicating better cognitive function
Quality of Life as measured by the Short-Form (36) Health Survey
Quality of life will be assessed with the Short-Form (36) Health Survey, measured from 0 to 100 with higher scores indicating better quality of life
Quality of Life as measured by the Short-Form (36) Health Survey
Quality of life will be assessed with the Short-Form (36) Health Survey, measured from 0 to 100 with higher scores indicating better quality of life
Quality of Life as measured by the Short-Form (36) Health Survey
Quality of life will be assessed with the Short-Form (36) Health Survey, measured from 0 to 100 with higher scores indicating better quality of life
Full Information
NCT ID
NCT05004558
First Posted
May 21, 2021
Last Updated
August 9, 2021
Sponsor
Drexel University
Collaborators
Mercy Health
1. Study Identification
Unique Protocol Identification Number
NCT05004558
Brief Title
Effects of Remote-based Resistance Training on Cardiometabolic Risk Factors, Cognitive Function, and Quality of Life in Adults Living With Alzheimer's Disease and/or Related Dementias
Official Title
Effects of a 24-week Remote-based Resistance Training Program on Parameters of the Metabolic Syndrome, Cognitive Function, and Quality of Life in Older Adults Living With Mild Cognitive Impairment and Alzheimer's Disease and/or a Related Dementia
Study Type
Interventional
2. Study Status
Record Verification Date
August 2021
Overall Recruitment Status
Unknown status
Study Start Date
September 1, 2021 (Anticipated)
Primary Completion Date
March 2022 (Anticipated)
Study Completion Date
June 2022 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Drexel University
Collaborators
Mercy Health
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The investigators aim to study the effects of a 24-week remote-based resistance exercise training program on cardiovascular disease risk factors, cognitive function, and quality of life in older adults living with mild cognitive impairment or Alzheimer's Disease and/or a related dementia. Data for this study will be collected at the beginning, middle, and end of the resistance training program. Participants of this study will receive a baseline health-fitness assessment at the beginning of the study. Measurements of resting blood pressure, fasting blood glucose and lipids, waist and hip circumferences, height and weight, cognitive function and quality of life will be collected at the health-fitness assessment. Participants will then receive supervised remote-based resistance exercise training with Therabands, 3 days per week for 12 weeks before receiving a second 12-week health-fitness assessment in the middle of the intervention. Participants will then receive 12 additional weeks of supervised remote-based resistance exercise training with Therabands, 3 days per week for 12 weeks before receiving a third 24-week health fitness assessment at the end of the study.
Detailed Description
The investigators aim to study the effects of a 24-week remote-based resistance exercise training program on cardiovascular disease risk factors, cognitive function, and quality of life in older adults living with mild cognitive impairment or Alzheimer's Disease and/or a related dementia. Data for this study will be collected at the beginning, middle, and end of the resistance training program. Measurements of resting blood pressure will be collected with an automated blood pressure monitor. Fasting blood glucose and lipids will be retrieved from the electronic medical record or from a finger stick. Waist and hip circumferences will be collected with a tape measure. Height and weight will be collected with a physician scale. Cognitive function and quality of life will be collected from interviews using the Montreal Cognitive Assessment and Short-Form (36) Health Survey. All data collected from this study will be de-identified using the "Safe-Harbor" method, which minimizes exposure of personal health information by providing each participant with a unique participant-ID and only providing access to those who are listed and approved for access privileges. Data collected for this study will also be stored on an encrypted and password- protected hard drive, and data analyzed will be performed with the Statistical Package for the Social Sciences using analyses of covariance.
When participants are enrolled in the study, he/she will be grouped on the basis of their cognitive function status from the Montreal Cognitive Assessment. All participants will then receive supervised remote-based resistance exercise training with Therabands, 3 days per week for 24 weeks. The risks of participating in exercise programs are minimal. Some of the possible risks of participating in resistance exercise include becoming tired and/or experiencing delayed onset muscle soreness, leg cramping, or muscle strain from performing resistance exercise. There are several benefits from engaging in resistance exercise programs. Participants of this study will receive health-fitness assessment at the beginning, middle, and end of the study, and as such, will benefit from being made aware of their cardiovascular disease risk factors, cognitive function, and quality of life. Other possible benefits from participation in the resistance exercise program may include improvements in muscular size and strength and/or activities of daily living.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dementia, Alzheimer Disease, Dementia, Vascular, Lewy Body Disease, Frontotemporal Dementia, Mild Cognitive Impairment, Aging, Hypertension, Obesity, Abdominal, Obesity, Body Weight, Blood Pressure, Blood Glucose, High, Blood Glucose, Low, Dyslipidemias, Quality of Life, Cognitive Impairment
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
36 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Remote-based Resistance Exercise Training
Arm Type
Experimental
Arm Description
All participants enrolled in the trial will receive supervised remote-based resistance exercise training. The exercises will be performed with the use of Therabands and will include 8-10 exercises performed for 1 set of 15 repetitions, performed 3 days per week for 24 weeks.
Intervention Type
Other
Intervention Name(s)
Remote-based Resistance Exercise Training
Intervention Description
All participants enrolled in the trial will receive supervised remote-based resistance exercise training. The exercises will be performed with the use of Therabands and will include 8-10 exercises performed for 1 set of 15 repetitions, performed 3 days per week for 24 weeks.
Primary Outcome Measure Information:
Title
Resting systolic blood pressure, measured in mmHg from 0 and above with higher numbers indicating higher blood pressure
Description
Resting systolic blood pressure will be measured with an automated blood pressure device, measured in mmHg from 0 and above with higher numbers indicating higher blood pressure
Time Frame
Baseline
Title
Resting systolic blood pressure, measured in mmHg from 0 and above with higher numbers indicating higher blood pressure
Description
Resting systolic blood pressure will be measured with an automated blood pressure device, measured in mmHg from 0 and above with higher numbers indicating higher blood pressure
Time Frame
12 weeks
Title
Resting systolic blood pressure, measured in mmHg from 0 and above with higher numbers indicating higher blood pressure
Description
Resting systolic blood pressure will be measured with an automated blood pressure device, measured in mmHg from 0 and above with higher numbers indicating higher blood pressure
Time Frame
24 weeks
Title
Resting diastolic blood pressure, measured in mmHg from 0 and above with higher numbers indicating higher blood pressure
Description
Resting diastolic blood pressure will be measured with an automated blood pressure device, measured in mmHg from 0 and above with higher numbers indicating higher blood pressure
Time Frame
Baseline
Title
Resting diastolic blood pressure, measured in mmHg from 0 and above with higher numbers indicating higher blood pressure
Description
Resting diastolic blood pressure will be measured with an automated blood pressure device, measured in mmHg from 0 and above with higher numbers indicating higher blood pressure
Time Frame
12 weeks
Title
Resting diastolic blood pressure, measured in mmHg from 0 and above with higher numbers indicating higher blood pressure
Description
Resting diastolic blood pressure will be measured with an automated blood pressure device, measured in mmHg from 0 and above with higher numbers indicating higher blood pressure
Time Frame
24 weeks
Title
Height, red with a stadiometer in inches from 0 and above with higher numbers indicating taller height
Description
Height will be measured with a stadiometer in inches from 0 and above with higher numbers indicating taller height
Time Frame
Baseline
Title
Height, red with a stadiometer in inches from 0 and above with higher numbers indicating taller height
Description
Height will be measured with a stadiometer in inches from 0 and above with higher numbers indicating taller height
Time Frame
12 weeks
Title
Height, red with a stadiometer in inches from 0 and above with higher numbers indicating taller height
Description
Height will be measured with a stadiometer in inches from 0 and above with higher numbers indicating taller height
Time Frame
24 weeks
Title
Weight, ured with a physican scale in pounds from 0 and above with higher numbers indicating heavier weight
Description
Weight will be measured with a physican scale in pounds from 0 and above with higher numbers indicating heavier weight
Time Frame
Baseline
Title
Weight, ured with a physican scale in pounds from 0 and above with higher numbers indicating heavier weight
Description
Weight will be measured with a physican scale in pounds from 0 and above with higher numbers indicating heavier weight
Time Frame
12 weeks
Title
Weight, ured with a physican scale in pounds from 0 and above with higher numbers indicating heavier weight
Description
Weight will be measured with a physican scale in pounds from 0 and above with higher numbers indicating heavier weight
Time Frame
24 weeks
Title
Body mass index, measured in meters squared, from 0 and above wiith larger values indicating a higher body mass index
Description
Body mass index will be measured as the weight measured in kilograms divided by the height measured in meters squared, from 0 and above wiith larger values indicating a higher body mass index
Time Frame
Baseline
Title
Body mass index, measured in meters squared, from 0 and above wiith larger values indicating a higher body mass index
Description
Body mass index will be measured as the weight measured in kilograms divided by the height measured in meters squared, from 0 and above wiith larger values indicating a higher body mass index
Time Frame
12 weeks
Title
Body mass index, measured in meters squared, from 0 and above wiith larger values indicating a higher body mass index
Description
Body mass index will be measured as the weight measured in kilograms divided by the height measured in meters squared, from 0 and above wiith larger values indicating a higher body mass index
Time Frame
24 weeks
Title
Waist circumference, red in inches with a Gulick tape measure from 0 and above with higher numbers indicating a larger waist circumference
Description
Waist circumference will be measured in inches with a Gulick tape measure from 0 and above with higher numbers indicating a larger waist circumference
Time Frame
Baseline
Title
Waist circumference, red in inches with a Gulick tape measure from 0 and above with higher numbers indicating a larger waist circumference
Description
Waist circumference will be measured in inches with a Gulick tape measure from 0 and above with higher numbers indicating a larger waist circumference
Time Frame
12 weeks
Title
Waist circumference, red in inches with a Gulick tape measure from 0 and above with higher numbers indicating a larger waist circumference
Description
Waist circumference will be measured in inches with a Gulick tape measure from 0 and above with higher numbers indicating a larger waist circumference
Time Frame
24 weeks
Title
Hip circumference, sured in inches with a Gulick tape measure from 0 and above with higher numbers indicating a larger waist circumference
Description
Hip circumference will be measured in inches with a Gulick tape measure from 0 and above with higher numbers indicating a larger waist circumference
Time Frame
Baseline
Title
Hip circumference, sured in inches with a Gulick tape measure from 0 and above with higher numbers indicating a larger waist circumference
Description
Hip circumference will be measured in inches with a Gulick tape measure from 0 and above with higher numbers indicating a larger waist circumference
Time Frame
12 weeks
Title
Hip circumference, sured in inches with a Gulick tape measure from 0 and above with higher numbers indicating a larger waist circumference
Description
Hip circumference will be measured in inches with a Gulick tape measure from 0 and above with higher numbers indicating a larger waist circumference
Time Frame
24 weeks
Title
Blood glucose, measured in mg/dL from 0 and above with larger values indicating a higher blood glucose concentration
Description
Blood glucose will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher blood glucose concentration
Time Frame
Baseline
Title
Blood glucose, measured in mg/dL from 0 and above with larger values indicating a higher blood glucose concentration
Description
Blood glucose will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher blood glucose concentration
Time Frame
12 weeks
Title
Blood glucose, measured in mg/dL from 0 and above with larger values indicating a higher blood glucose concentration
Description
Blood glucose will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher blood glucose concentration
Time Frame
24 weeks
Title
High density lipoprotein cholesterol, ed in mg/dL from 0 and above with larger values indicating a higher high density lipoprotein concentrations, a desirable finding
Description
High density lipoprotein cholesterol will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher high density lipoprotein concentrations, a desirable finding
Time Frame
Baseline
Title
High density lipoprotein cholesterol, ed in mg/dL from 0 and above with larger values indicating a higher high density lipoprotein concentrations, a desirable finding
Description
High density lipoprotein cholesterol will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher high density lipoprotein concentrations, a desirable finding
Time Frame
12 weeks
Title
High density lipoprotein cholesterol, ed in mg/dL from 0 and above with larger values indicating a higher high density lipoprotein concentrations, a desirable finding
Description
High density lipoprotein cholesterol will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher high density lipoprotein concentrations, a desirable finding
Time Frame
24 weeks
Title
Low density lipoprotein cholesterol, measured in mg/dL from 0 and above with larger values indicating a higher low density lipoprotein concentrations, an undesirable finding
Description
Low density lipoprotein cholesterol will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher low density lipoprotein concentrations, an undesirable finding
Time Frame
Baseline
Title
Low density lipoprotein cholesterol, measured in mg/dL from 0 and above with larger values indicating a higher low density lipoprotein concentrations, an undesirable finding
Description
Low density lipoprotein cholesterol will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher low density lipoprotein concentrations, an undesirable finding
Time Frame
12 weeks
Title
Low density lipoprotein cholesterol, measured in mg/dL from 0 and above with larger values indicating a higher low density lipoprotein concentrations, an undesirable finding
Description
Low density lipoprotein cholesterol will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher low density lipoprotein concentrations, an undesirable finding
Time Frame
24 weeks
Title
Triglycerides, measured in mg/dL from 0 and above with larger values indicating a higher triglyceride concentrations, an undesirable finding
Description
Triglycerides will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher triglyceride concentrations, an undesirable finding
Time Frame
Baseline
Title
Triglycerides, measured in mg/dL from 0 and above with larger values indicating a higher triglyceride concentrations, an undesirable finding
Description
Triglycerides will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher triglyceride concentrations, an undesirable finding
Time Frame
12 weeks
Title
Triglycerides, measured in mg/dL from 0 and above with larger values indicating a higher triglyceride concentrations, an undesirable finding
Description
Triglycerides will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher triglyceride concentrations, an undesirable finding
Time Frame
24 weeks
Title
Total cholesterol, measured in mg/dL from 0 and above with larger values indicating a higher total cholesterol concentrations, an undesirable finding
Description
Total cholesterol will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher total cholesterol concentrations, an undesirable finding
Time Frame
Baseline
Title
Total cholesterol, measured in mg/dL from 0 and above with larger values indicating a higher total cholesterol concentrations, an undesirable finding
Description
Total cholesterol will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher total cholesterol concentrations, an undesirable finding
Time Frame
12 weeks
Title
Total cholesterol, measured in mg/dL from 0 and above with larger values indicating a higher total cholesterol concentrations, an undesirable finding
Description
Total cholesterol will be measured with a Cholestech LDX analyzer via finger sticking, measured in mg/dL from 0 and above with larger values indicating a higher total cholesterol concentrations, an undesirable finding
Time Frame
24 weeks
Secondary Outcome Measure Information:
Title
Cognitive Function as Measured by the Montreal Cognitive Assessment
Description
Cognitive function will be assessed with the Montreal Cognitive Assessment Screen, measured from 0 to 30 with higher scores indicating better cognitive function
Time Frame
Baseline
Title
Cognitive Function as Measured by the Montreal Cognitive Assessment
Description
Cognitive function will be assessed with the Montreal Cognitive Assessment Screen, measured from 0 to 30 with higher scores indicating better cognitive function
Time Frame
12 weeks
Title
Cognitive Function as Measured by the Montreal Cognitive Assessment
Description
Cognitive function will be assessed with the Montreal Cognitive Assessment Screen, measured from 0 to 30 with higher scores indicating better cognitive function
Time Frame
24 weeks
Title
Quality of Life as measured by the Short-Form (36) Health Survey
Description
Quality of life will be assessed with the Short-Form (36) Health Survey, measured from 0 to 100 with higher scores indicating better quality of life
Time Frame
Baseline
Title
Quality of Life as measured by the Short-Form (36) Health Survey
Description
Quality of life will be assessed with the Short-Form (36) Health Survey, measured from 0 to 100 with higher scores indicating better quality of life
Time Frame
12 weeks
Title
Quality of Life as measured by the Short-Form (36) Health Survey
Description
Quality of life will be assessed with the Short-Form (36) Health Survey, measured from 0 to 100 with higher scores indicating better quality of life
Time Frame
24 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
55 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
55 years of age or older
Sedentary or not meeting the current physical activity guidelines of at least 150 minutes of moderate-to-vigorous physical activity per week
Live with or have a primary in-home caregiver or legal representative who can be physically present during the remote-based exercise sessions
Have access to a computer, tablet, or smartphone with internet and webcam access for the HIPAA compliant virtual Zoom meetings.
Exclusion Criteria:
Younger than 55 years of age
Accustomed to resistance exercise training during the previous year
Live with known or suggestive uncontrolled cardiovascular, metabolic, and/or renal disease
Live with musculoskeletal injury that precludes their ability to perform remote-based, resistance exercise training
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Effects of Remote-based Resistance Training on Cardiometabolic Risk Factors, Cognitive Function, and Quality of Life in Adults Living With Alzheimer's Disease and/or Related Dementias
We'll reach out to this number within 24 hrs